© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart
aDepartment of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA 30365-2225, USA
bDepartment of Hematology/Oncology, Emory University School of Medicine, Atlanta, GA 30365-2225, USA
* Corresponding author. Tel.: +1-404-686-2511; fax: +1-404-686-4888 jvinten{at}emory.edu
Objective: Recent studies suggest that ischemic preconditioning (IPC) inhibits myocardial apoptosis after ischemia and reperfusion. This study tested the hypothesis that IPC reduces ischemia/reperfusion-induced myocardial apoptosis by inhibiting neutrophil (PMN) accumulation and altering expression of Bcl-2 and Bax proteins. Methods: Eighteen rats were subjected to 30 min of left coronary artery occlusion followed by 180 min of reperfusion with IPC (5 min ischemia and 10 min of reperfusion, n=10) or without IPC (n=8). Myocardial apoptosis was detected histologically using the terminal transferase UTP nick end labeling (TUNEL) assay and confirmed by DNA ladder on agarose gel electrophoresis. PMN accumulation was detected immunohistochemically with anti-rat CD18 antibody (WT3) and expression of Bcl-2 and Bax proteins was analyzed using Western blot assay. Results: IPC significantly decreased TUNEL positive cells (% total nuclei) in the ischemic zone from 28.6±2.8 to 3.4± 0.9 (P<0.05), consistent with the absence of DNA ladders in the IPC group. IPC significantly attenuated PMN accumulation (cells/mm2 myocardium) in the ischemic zone from 243±19 to 118±19 (P<0.05). By regression analysis, there was a significant correlation between TUNEL positive cells and accumulated CD18 positive PMNs in the ischemic zone (r=0.8, P<0.001), which was shifted downward by IPC. Densitometrically, IPC significantly attenuated the ischemia/reperfusion-upregulated expression of Bax protein in the ischemic zone from 204±57% in the control group to 76±7% (P<0.05), while the expression of Bcl-2 was not different from the non-ischemic zone in either group. Conclusion: These data suggest that ischemic preconditioning may reduce myocardial apoptosis by inhibiting PMN accumulation and down-regulating expression of Bax.
KEYWORDS Apoptosis; Ischemia; Leukocytes; Preconditioning; Reperfusion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. R. Powell and A. Divald The ubiquitin-proteasome system in myocardial ischaemia and preconditioning Cardiovasc Res, October 27, 2009; (2009) cvp321v3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bott-Flugel, H.-J. Weig, H. Uhlein, M. Nabauer, K.-L. Laugwitz, and M. Seyfarth Quantitative analysis of apoptotic markers in human end-stage heart failure Eur J Heart Fail, February 1, 2008; 10(2): 129 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Choi, S.-H. Kim, Y.-S. Chun, Y.-S. Cho, J.-W. Park, and M.-S. Kim In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Experimental Biology and Medicine, April 1, 2006; 231(4): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Feng, C. Bianchi, J. L. Sandmeyer, and F. W. Sellke Bradykinin Preconditioning Improves the Profile of Cell Survival Proteins and Limits Apoptosis After Cardioplegic Arrest Circulation, August 30, 2005; 112(9_suppl): I-190 - I-195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Liang, E. Gao, L. Tao, H. Liu, Y. Qu, T. A Christopher, B. L Lopez, and X. L Ma Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis--role of NOS isoforms Cardiovasc Res, June 1, 2004; 62(3): 568 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, S. Bae, and L. Zhang Effect of prenatal hypoxia on heat stress-mediated cardioprotection in adult rat heart Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1712 - H1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz and G. Heusch Connexin 43 and ischemic preconditioning Cardiovasc Res, May 1, 2004; 62(2): 335 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Argaud, A.-F. Prigent, L. Chalabreysse, J. Loufouat, M. Lagarde, and M. Ovize Ceramide in the antiapoptotic effect of ischemic preconditioning Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H246 - H251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Argaud, O. Gateau-Roesch, L. Chalabreysse, L. Gomez, J. Loufouat, F. Thivolet-Bejui, D. Robert, and M. Ovize Preconditioning delays Ca2+-induced mitochondrial permeability transition Cardiovasc Res, January 1, 2004; 61(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Zhao, J. S. Corvera, M. E. Halkos, F. Kerendi, N.-P. Wang, R. A. Guyton, and J. Vinten-Johansen Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol, August 1, 2003; 285(2): H579 - H588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang Effect of Fetal Hypoxia on Heart Susceptibility to Ischemia and Reperfusion Injury in the Adult Rat Reproductive Sciences, July 1, 2003; 10(5): 265 - 274. [Abstract] [PDF]
|
|
|
|
|
|
E. Hochhauser, S. Kivity, D. Offen, N. Maulik, H. Otani, Y. Barhum, H. Pannet, V. Shneyvays, A. Shainberg, V. Goldshtaub, et al. Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2351 - H2359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A J Krijnen, R Nijmeijer, C J L M Meijer, C A Visser, C E Hack, and H W M Niessen Apoptosis in myocardial ischaemia and infarction J. Clin. Pathol., November 1, 2002; 55(11): 801 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Zhao and J. Vinten-Johansen Myocardial apoptosis and ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 438 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, G. Azhar, K. Nagano, and J. Y. Wei Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Holleyman and D. F Larson Apoptosis in the ischemic reperfused myocardium Perfusion, December 1, 2001; 16(6): 491 - 502. [Abstract] [PDF]
|
|
|
|
|
|
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch Signal transduction of ischemic preconditioning Cardiovasc Res, November 1, 2001; 52(2): 181 - 198. [Full Text] [PDF]
|
|
|
|
 |
|
 B. O'Rourke Myocardial KATP Channels in Preconditioning Circ. Res., November 10, 2000; 87(10): 845 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Borgers, L.-M. Voipio-Pulkki, and S. Izumo Apoptosis Cardiovasc Res, February 1, 2000; 45(3): 525 - 527. [Full Text] [PDF]
|
|